Canada Research Chair in Molecular Characterization of Neurological Diseases
Carles Vilariño-Güell, an Assistant Professor in the Department of Medical Genetics, uses next-generation sequencing technologies to identify the genetic causes of multiple sclerosis, a disease for which there is no cure. His research will build on a Canada-wide effort spanning over 20 years to obtain thousands of biological samples and detailed clinical information from MS patients and their families. This amazing resource combined with technological advances is allowing the identification of the molecular components implicated in onset and progression of this disease. He expects his team’s research will unravel the molecular etiology of MS, and lead to the development of more efficacious drugs that will provide symptomatic benefit by halting the onset of disease and its progression.